Compare Amphastar Pharmaceuticals Inc (AMPH) vs First Trust NASDAQ Clean Edge Green Energy Idx Fd (QCLN) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

QCLN trades at $55.7, down 1.5% amid a bearish technical setup with moving averages and ADX signaling selling pressure. The clean energy ETF faces mixed sentiment as policy uncertainty under the Trump administration threatens $121 billion in renewable investments, while global demand for low-emission power grows. Key support sits at $55 with resistance at $57.

Outlook remains cautious due to regulatory headwinds and supply chain costs, but long-term exposure to energy transition themes offers potential. Risks include U.S.-China trade tensions and volatile commodity prices affecting solar and wind projects.